Ms. Albazzaz is an accomplished regulatory affairs and pharmacovigilance executive, having led global regulatory strategy, risk-management strategy and pharmacovigilance. She most recently served as vice president of Risk Management for Lundbeck, Inc. (formerly Ovation Pharmaceuticals). Prior to that, she was vice president for International Regulatory Affairs at Ovation, where she was responsible for global pharmacovigilance.
Leo Sheridan, chief executive officer of Advanced Clinical, said, “We are honored to bring Eman’s caliber and experience to our team. Her commitment to life sciences innovation is unparalleled, and her insight is a critical asset to the industry and our company.”